Jo Lambert

10.8k total citations
213 papers, 5.6k citations indexed

About

Jo Lambert is a scholar working on Immunology, Dermatology and Molecular Biology. According to data from OpenAlex, Jo Lambert has authored 213 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Immunology, 64 papers in Dermatology and 43 papers in Molecular Biology. Recurrent topics in Jo Lambert's work include Psoriasis: Treatment and Pathogenesis (61 papers), Dermatology and Skin Diseases (39 papers) and melanin and skin pigmentation (35 papers). Jo Lambert is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (61 papers), Dermatology and Skin Diseases (39 papers) and melanin and skin pigmentation (35 papers). Jo Lambert collaborates with scholars based in Belgium, Netherlands and United States. Jo Lambert's co-authors include Mireille Van Gele, Reinhart Speeckaert, Liève Brochez, Nanja van Geel, Sofie De Schepper, Jean‐Marie Naeyaert, Marijn M. Speeckaert, Peter Dynoodt, Jean Naeyaert and Barbara Geusens and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Jo Lambert

205 papers receiving 5.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jo Lambert Belgium	42	1.7k	1.6k	1.6k	1.4k	507	213	5.6k
Xuejun Zhang China	40	836 0.5×	1.9k 1.2×	965 0.6×	1.6k 1.1×	436 0.9×	273	5.6k
James Varani United States	43	1.1k 0.7×	1.3k 0.8×	1.7k 1.1×	2.5k 1.7×	339 0.7×	123	7.1k
Alice P. Pentland United States	39	809 0.5×	636 0.4×	1.4k 0.9×	1.5k 1.1×	379 0.7×	94	5.9k
Mayumi Komine Japan	39	783 0.5×	2.4k 1.5×	2.5k 1.6×	1.1k 0.7×	326 0.6×	179	6.0k
Sang Ho Oh South Korea	36	1.0k 0.6×	531 0.3×	1.5k 0.9×	994 0.7×	289 0.6×	210	4.8k
Iltefat Hamzavi United States	51	3.7k 2.1×	1.3k 0.8×	5.2k 3.3×	731 0.5×	907 1.8×	249	8.5k
Jörg Reichrath Germany	48	538 0.3×	1.0k 0.6×	2.1k 1.3×	1.6k 1.1×	903 1.8×	215	6.8k
Chee‐Yin Chai Taiwan	46	410 0.2×	1.4k 0.9×	582 0.4×	3.3k 2.3×	1.2k 2.4×	400	8.9k
Cong Peng China	37	347 0.2×	1.5k 0.9×	423 0.3×	4.3k 3.0×	488 1.0×	191	6.6k
Hans F. Merk Germany	53	404 0.2×	1.4k 0.9×	3.9k 2.5×	1.4k 1.0×	591 1.2×	344	10.2k

Countries citing papers authored by Jo Lambert

Since Specialization

Citations

This map shows the geographic impact of Jo Lambert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo Lambert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo Lambert more than expected).

Fields of papers citing papers by Jo Lambert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo Lambert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo Lambert. The network helps show where Jo Lambert may publish in the future.

Co-authorship network of co-authors of Jo Lambert

This figure shows the co-authorship network connecting the top 25 collaborators of Jo Lambert. A scholar is included among the top collaborators of Jo Lambert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jo Lambert. Jo Lambert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alsoud, Dahham, Dirk Jan A. R. Moes, Zhigang Wang, et al.. (2024). Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic Drug Monitoring. 46(3). 291–308. 8 indexed citations

Wang, Ziyi, Laurentijn Tilleman, Filip Van Nieuwerburgh, et al.. (2024). Exposure–response relationship of guselkumab and the potential of serum proteomics in identifying predictive biomarker candidates in psoriasis. Journal of the European Academy of Dermatology and Venereology. 38(8). 1555–1565. 3 indexed citations

Kraaij, G. E. van der, Wouter Ouwerkerk, J. M. P. A. van den Reek, et al.. (2023). Adalimumab combined with methotrexate versus adalimumab monotherapy in psoriasis: Three‐year follow‐up data of a single‐blind randomized controlled trial. Journal of the European Academy of Dermatology and Venereology. 37(9). 1815–1824. 5 indexed citations

Kraaij, G. E. van der, Annelie H. Musters, S.P. Menting, et al.. (2023). Quantifying the Effect of Methotrexate on Adalimumab Response in Psoriasis by Pharmacokinetic–Pharmacodynamic Modeling. Journal of Investigative Dermatology. 144(4). 794–801.e6. 3 indexed citations

Augustin, Matthias, Rachel Sommer, E. Daudén, et al.. (2023). Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study). BMJ Open. 13(2). e060536–e060536. 8 indexed citations

Blauvelt, Andrew, Phoebe Rich, Howard Sofen, et al.. (2023). Deucravacitinib, a selective, allosteric tyrosine kinase 2 inhibitor, in scalp psoriasis: A subset analysis of two phase 3 randomized trials in plaque psoriasis. Journal of the American Academy of Dermatology. 90(4). 775–782. 12 indexed citations

Papp, Kim, Barbara Melosky, Sandeep Sehdev, et al.. (2023). Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel. Dermatology and Therapy. 13(4). 867–889. 10 indexed citations

Hoorens, Isabelle, et al.. (2023). Value in psoriasis (IRIS) trial: implementing value-based healthcare in psoriasis management – a 1-year prospective clinical study to evaluate feasibility and value creation. BMJ Open. 13(5). e067504–e067504. 1 indexed citations

Kraaij, G. E. van der, J. M. P. A. van den Reek, S.P. Menting, et al.. (2022). Adalimumab with Methotrexate vs. Adalimumab Monotherapy in Psoriasis: First-Year Results of a Single-Blind Randomized Controlled Trial. Journal of Investigative Dermatology. 142(9). 2375–2383.e6. 15 indexed citations

10.

Stove, Christophe P., et al.. (2022). Promising Tools to Facilitate the Implementation of TDM of Biologics in Clinical Practice. Journal of Clinical Medicine. 11(11). 3011–3011. 8 indexed citations

11.

Balak, Deepak, et al.. (2022). Initiating value‐based healthcare in psoriasis: Proposing a value‐based outcome set for daily clinical practice. Journal of the European Academy of Dermatology and Venereology. 37(3). 528–539. 5 indexed citations

12.

Lambert, Jo, et al.. (2020). Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA‐PSO: Belgian Evidence‐based Treatment Advice in Psoriasis; part 2). Journal of the European Academy of Dermatology and Venereology. 34(9). 1914–1923. 30 indexed citations

13.

Thaçi, Diamant, Gil Yosipovitch, Kim Papp, et al.. (2015). Effects of apremilast on pruritus in patients with moderate to severe plaque psoriasis : results from the ESTEEM 1 and 2 trials. Ghent University Academic Bibliography (Ghent University). 1 indexed citations

14.

Schepper, Sofie De, et al.. (2015). Immunohistochemical analysis of the JAK family members in inflammatory skin diseases reveals increased expression of JAK1 and JAK3. Journal of Investigative Dermatology. 135. 1 indexed citations

15.

Lambert, Jo, Alexander Nast, Frank O. Nestlé, & Jörg C. Prinz. (2015). Practical guidance on immunogenicity to biologic agents used in the treatment of psoriasis: What can be learnt from other diseases?. Journal of Dermatological Treatment. 26(6). 520–527. 8 indexed citations

16.

Gele, Mireille Van, Barbara Geusens, Liève Brochez, Reinhart Speeckaert, & Jo Lambert. (2011). Three-dimensional skin models as tools for transdermal drug delivery: challenges and limitations. Expert Opinion on Drug Delivery. 8(6). 705–720. 70 indexed citations

17.

Clark, Rachael A., Susan S. Huang, George F. Murphy, et al.. (2008). Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells. The Journal of Experimental Medicine. 205(10). 2221–2234. 170 indexed citations

18.

Eberhart-Phillips, J, et al.. (2000). Internet use amongst New Zealand general practitioners.. PubMed. 113(1108). 135–7. 25 indexed citations

19.

Lambert, Jo, et al.. (1963). [PSYCHIATRIC AND SOCIAL SERVICE TO AGED PERSONS].. PubMed. 34. 1137–46.

20.

Lambert, Jo, et al.. (1959). [Employment placement of mental deficient patients].. PubMed. 27(2). 208–27; discussion 227. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact